Benzinga's Top Initiations


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


Analysts at Cantor Fitzgerald initiated coverage on Ross Stores, Inc.

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

(NASDAQ: ROST) with a Hold rating. The target price for Ross Stores is set to $110. Ross Stores' shares closed at $102.29 yesterday.Analysts at Wunderlich initiated coverage on Jernigan Capital Inc. (NYSE: JCAP) with a Buy rating. The target price for Jernigan Capital is set to $25. Jernigan Capital's shares closed at $21.30 yesterday.Analysts at FBR Capital initiated coverage on Regulus Therapeutics Inc (NASDAQ: RGLS) with a Outperform rating. The target price for Regulus Therapeutics is set to $30. Regulus Therapeutics' shares closed at $17.18 yesterday.Stifel Nicolaus initiated coverage on Summit Materials Inc (NYSE: SUM) with a Buy rating. The target price for Summit Materials is set to $28. Summit Materials' shares closed at $24.22 yesterday.FBR Capital initiated coverage on

Want Private Access to Benzinga Analyst?

Check out the latest strategies our team of experts are using every week so that you can always adapt to the market like the pros!—Get FULL Access to This Week's Webinar Here.


Genocea Biosciences Inc (NASDAQ: GNCA) with a Outperform rating. The target price for Genocea Biosciences is set to $20. Genocea Biosciences' shares closed at $12.93 yesterday.Analysts at FBR Capital initiated coverage on Zafgen Inc (NASDAQ: ZFGN) with a Outperform rating. The target price for Zafgen is set to $60. Zafgen's shares closed at $36.58 yesterday.Raymond James initiated coverage on Community Bank System, Inc. (NYSE: CBU) with a Market Perform rating. Community Bank System's shares closed at $35.64 yesterday.Analysts at FBR Capital initiated coverage on Biocryst Pharmaceuticals, Inc. (NASDAQ: BCRX) with a Outperform rating. The target price for Biocryst Pharmaceuticals is set to $18. Biocryst Pharmaceuticals' shares closed at $10.29 yesterday.FBR Capital initiated coverage on Corcept Therapeutics Incorporated (NASDAQ: CORT) with a Outperform rating. The target price for Corcept Therapeutics is set to $12. Corcept Therapeutics' shares closed at $5.98 yesterday.

27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


Posted In: InitiationAnalyst RatingsTop Initiations